Cancer Treatment Centers of America

Targeted therapy for leukemia

immunotherapy

Targeted therapy for leukemia

Unlike standard chemotherapy which affects all cells in the body, targeted therapy directly seeks out leukemia cells, helping to reduce damage to healthy cells and minimize side effects.

These therapies are commonly used at Cancer Treatment Centers of America® (CTCA) for the treatment of CLL. Some examples are alemtuzumab (Campath®) and rituximab (Rituxan®).

Targeted therapy may be used in combination with other leukemia treatments, such as chemotherapy. Your care team will work together to develop a personalized treatment plan tailored to your unique diagnosis and needs.

Helping you maintain your quality of life

Targeted therapy may cause side effects that interfere with your ability to participate in activities you enjoy. For example, you may experience a reduction in blood counts, which may lead to fatigue and risk of infection. Other potential side effects may include fever, chills, headache, rash, nausea and shortness of breath.

Throughout your leukemia treatment, your care team works together to offer supportive care services, such as naturopathic medicine, nutrition therapy, pain management, mind-body medicine, oncology rehabilitation and spiritual support. These therapies may help reduce treatment-related side effects so you can better tolerate treatment while maintaining your quality of life.


Leukemia targeted therapies